These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25490818)

  • 1. [Expression of serum and urinary vascular endothelial growth factor-A and epidermal growth factor-like domain 7 in proliferating hemangioma treated with propranolol].
    Bin L; Manli C; Jie L; Xiaopeng Y; Zhaoquan L; Zhongcheng G
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2014 Oct; 32(5):441-5. PubMed ID: 25490818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of propranolol gel on plasma VEGF, bFGF and MMP-9 in proliferating infantile hemangiomas of superficial type].
    Yujuan T; Shaoquan C; Zaizhong Z; Shuming C; Guoliang H; Lie W
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Jul; 31(4):268-73. PubMed ID: 26665926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients.
    Yuan WL; Jin ZL; Wei JJ; Liu ZY; Xue L; Wang XK
    Br J Oral Maxillofac Surg; 2013 Oct; 51(7):656-61. PubMed ID: 23291092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The change of serum vascular endothelial growth factor and matrix metalloproteinases-9 in proliferative hemangioma treated with propranolol].
    Zhao ZF; Lü RR; Huo R; Fu HB; Xu GQ
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Sep; 27(5):359-61. PubMed ID: 22259987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy.
    Chen XD; Ma G; Huang JL; Chen H; Jin YB; Ye XX; Hu XJ; Lin XX
    Pediatr Dermatol; 2013; 30(5):549-53. PubMed ID: 23909679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas?
    Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M
    Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
    Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
    Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of GLUT1, IGF-2, VEGF, FGF 1, and angiopoietin 2 in infantile hemangioma.
    Aydin Köker S; Kömüroğlu AU; Köksoy AY; Şiraz ÜG; Tekin E; Köker A
    Arch Pediatr; 2021 May; 28(4):296-300. PubMed ID: 33715934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of VEGF and bFGF in infantile hemangiomas treated with propranolol.
    Şen HS; Yalçın B; Canpınar H; Ocak S; Akyüz C
    Turk J Pediatr; 2020; 62(6):979-985. PubMed ID: 33372436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma.
    Makkeyah SM; Elseedawy ME; Abdel-Kader HM; Mokhtar GM; Ragab IA
    Pediatr Hematol Oncol; 2022 Apr; 39(3):215-224. PubMed ID: 34477031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and tissue profile of VEGF and its receptors VGFR1/R2 in children with infantile hemangiomas on systemic propranolol treatment.
    Przewratil P; Kobos J; Wnęk A; Szemraj J; Wyrzykowski D; Chrzanowska B; Andrzejewska E; Taran K
    Immunol Lett; 2016 Jul; 175():44-9. PubMed ID: 27178307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol.
    Zhu L; Xie J; Liu Z; Huang Z; Huang M; Yin H; Qi W; Yang Z; Zhou T; Gao G; Zhang J; Yang X
    Cancer Sci; 2018 Jun; 109(6):1981-1994. PubMed ID: 29664206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the role of serum vascular endothelial growth factor and urinary basic fibroblast growth factor in differential diagnosis of vascular anomalies].
    Zhang L; Chen Q; Li D; Li XW; Wang HG; Li GZ
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1092-5. PubMed ID: 21609589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of serum vascular endothelial growth factor in infantile hemangiomas.
    Paria S; Mendiratta V; Chander R; Jain A; Mittal S
    Indian J Dermatol Venereol Leprol; 2019; 85(1):65-68. PubMed ID: 29469063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
    Pan WK; Li P; Guo ZT; Huang Q; Gao Y
    Pediatr Blood Cancer; 2015 Aug; 62(8):1414-20. PubMed ID: 25728347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell.
    Zhang L; Mai HM; Zheng J; Zheng JW; Wang YA; Qin ZP; Li KL
    Int J Clin Exp Pathol; 2014; 7(1):48-55. PubMed ID: 24427325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol induces regression of hemangioma cells through HIF-1α-mediated inhibition of VEGF-A.
    Chim H; Armijo BS; Miller E; Gliniak C; Serret MA; Gosain AK
    Ann Surg; 2012 Jul; 256(1):146-56. PubMed ID: 22580939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol represses infantile hemangioma cell growth through the β2-adrenergic receptor in a HIF-1α-dependent manner.
    Li P; Guo Z; Gao Y; Pan W
    Oncol Rep; 2015 Jun; 33(6):3099-107. PubMed ID: 25872592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Cytochrome P450 2D6 Polymorphisms on the Efficacy of Oral Propranolol in Treating Infantile Hemangioma.
    Wang L; Zheng K; Li X; Wang Y; Xu Q
    Biomed Res Int; 2020; 2020():8732871. PubMed ID: 32219146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to propranolol in infantile hemangioma.
    Sirachainan N; Lekanan W; Thammagasorn Y; Wanitkun S; Kadegasem P; Chunharas A
    Pediatr Int; 2016 Jul; 58(7):662-5. PubMed ID: 27460401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.